Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2025-12-25 @ 2:04 AM
NCT ID:
NCT05050760
Brief Summary:
To evaluate the safety and feasibility of DCF combined with camrelizumab in the treatment of locally advanced ESCC
Detailed Description:
Primary outcome:
To evaluate the safety and feasibility of DCF combined with camrelizumab in the treatment of locally advanced ESCC
Secondary outcome:
pathologic complete response (pCR)、Major Pathologic Response（MPR）、R0 resection rate、Objective response rate（ORR）、Disease free survival（DFS）、Relief rate and safety of dysphagia
Study:
NCT05050760
Study Brief:
Protocol Section:
NCT05050760